U.S. NeuroSurgical Holdings, Inc., through its subsidiaries, owns and operates stereotactic radiosurgery centers that utilize gamma knife technology. More Details
Flawless balance sheet and undervalued.
Share Price & News
How has U.S. NeuroSurgical Holdings's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: USNU's share price has been volatile over the past 3 months.
7 Day Return
1 Year Return
Return vs Industry: USNU underperformed the US Healthcare industry which returned 21% over the past year.
Return vs Market: USNU underperformed the US Market which returned 13.8% over the past year.
Price Volatility Vs. Market
How volatile is U.S. NeuroSurgical Holdings's share price compared to the market and industry in the last 5 years?
Simply Wall St News
Is U.S. NeuroSurgical Holdings undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: USNU ($0.26) is trading below our estimate of fair value ($2.76)
Significantly Below Fair Value: USNU is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: USNU is good value based on its PE Ratio (8.6x) compared to the US Healthcare industry average (22.2x).
PE vs Market: USNU is good value based on its PE Ratio (8.6x) compared to the US market (17.6x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate USNU's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: USNU is good value based on its PB Ratio (0.6x) compared to the US Healthcare industry average (2.8x).
How is U.S. NeuroSurgical Holdings forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as U.S. NeuroSurgical Holdings has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
- Examine whether U.S. NeuroSurgical Holdings is trading at an attractive price based on how much it is expected to earn in the future, and relative to its industry peers and the wider market.
- While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on theOTC Markets Website. If you are looking for more of a qualitative research into the company, you can access U.S. NeuroSurgical Holdings's filings and announcementshere.
- Explore growth companies in the Healthcare industry.
How has U.S. NeuroSurgical Holdings performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: USNU has high quality earnings.
Growing Profit Margin: USNU became profitable in the past.
Past Earnings Growth Analysis
Earnings Trend: USNU's earnings have declined by 37.8% per year over the past 5 years.
Accelerating Growth: USNU has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: USNU has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (31.1%).
Return on Equity
High ROE: USNU's Return on Equity (7%) is considered low.
How is U.S. NeuroSurgical Holdings's financial position?
Financial Position Analysis
Short Term Liabilities: USNU's short term assets ($3.3M) exceed its short term liabilities ($1.6M).
Long Term Liabilities: USNU's short term assets ($3.3M) exceed its long term liabilities ($98.0K).
Debt to Equity History and Analysis
Debt Level: USNU is debt free.
Reducing Debt: USNU had no debt 5 years ago.
Debt Coverage: USNU has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: USNU has no debt, therefore coverage of interest payments is not a concern.
What is U.S. NeuroSurgical Holdings's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate USNU's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate USNU's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if USNU's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if USNU's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of USNU's dividend in 3 years as they are not forecast to pay a notable one for the US market.
How experienced are the management team and are they aligned to shareholders interests?
Alan Gold (75 yo)
Mr. Alan Gold has been the Chairman and President of U.S. NeuroSurgical Holdings, Inc. (formerly known as US Neurosurgical Inc.) since 1996 and serves as the Chief Executive Officer. He served as Principal ...
CEO Compensation Analysis
Compensation vs Market: Alan's total compensation ($USD0.00) is below average for companies of similar size in the US market ($USD604.44K).
Compensation vs Earnings: Alan's compensation has been consistent with company performance over the past year.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
U.S. NeuroSurgical Holdings, Inc.'s company bio, employee growth, exchange listings and data sources
- Name: U.S. NeuroSurgical Holdings, Inc.
- Ticker: USNU
- Exchange: OTCPK
- Founded: 1993
- Industry: Health Care Facilities
- Sector: Healthcare
- Market Cap: US$2.026m
- Shares outstanding: 7.79m
- Website: https://www.usneuro.com
Number of Employees
- U.S. NeuroSurgical Holdings, Inc.
- 2400 Research Boulevard
- Suite 325
- United States
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|USNU||OTCPK (Pink Sheets LLC)||Yes||Common Stock||US||USD||Oct 1999|
U.S. NeuroSurgical Holdings, Inc., through its subsidiaries, owns and operates stereotactic radiosurgery centers that utilize gamma knife technology. The gamma knife is a stereotactic radiosurgical device ...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/09/28 05:33|
|End of Day Share Price||2020/09/25 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.